Position of the Ibero-American Society of Neurourology and Urogynecology in relation to the use of synthetic suburethral meshes for the surgical treatment of female stress incontinence.

The aim of this paper is to stablish de position of the Ibero-American Society of Neurourology and Urogynecology (SINUG) in relation to the use of suburethral meshes for the surgical treatment of female stress incontinence.

Tension-free mid-urethral slings (MUS) have become the most popular procedure for the treatment of stress urinary incontinence (SUI). In July 2018, the British government announced a pause in the use of meshes for both pelvic organ prolapse (POP) and urinary incontinence (UI) treatment without differentiating whether the meshes were used for treating UI or POP. The decision was taken to stop their use until the publication of the updated UI and POP guidelines of the British National Health Service, which is available from April 2019. SINUG has reviewed the evidence and official position of different societies in relation to the safety and efficacy of MUS in the surgical treatment of incontinence differentiating them from meshes used to repair POP.

Data from synthetic mesh manufacturers indicate that in 2010, 300 000 women underwent surgical procedures to repair POP and approximately 260 000 were operated on for SUI. According to these estimates, approximately more than 80% of the surgical techniques for UI treatment were performed transvaginally with meshes.

Once reviewed evidence and position of different societies, the SINUG presents its vision in this communication, which is a summary of the document analysing the state of topic prepared by the society.

Neurourology and urodynamics. 2019 Oct 06 [Epub ahead of print]

Carlos Müller-Arteaga, Alicia Martín Martinez, Bárbara Padilla-Fernández, Pedro Blasco Hernández, Montserrat Espuña Pons, Francisco Cruz, Carlos Errando-Smet, Roberto Martínez-García, Eduardo Vicente Palacio, David Castro Díaz, Luis López-Fando, Blanca Madurga Patuel, Cristina Ros Cerro, Salvador Arlandis Guzmán

Reconstructive and Functional Urology Section, Urology Service, University Hospital Ourense, Valencia, Spain., Pelvic Floor Section, Gynecology and Obstetrics Service, Hospital Materno-Infantil de Canarias, Las Palmas de Gran Canaria, Spain., Functional Urology Section, Urology Service, University Hospital of Canary Islands, Tenerife, Spain., Functional Urology Section, Urology Service, University Hospital Valme, Sevilla, Spain., Gynecological Ecoraphy Section, ICGON, Clinic Hospital, Barcelona, Spain., Head of Urology Department, Sao Joao Hospital, Porto, Portugal., Head of Functional Urology Section, Urology Service, Fundación Puigvert, Barcelona, Spain., Functional Urology, Urology Service, Clinic Hospital, Valencia, Spain., Functional Urology Section, Urology Service, Corporación Sanitaria Parc Taulí, Sabadell, Spain., Functional and Reconstructive Urology Section, Urology Service, Hospital Ramón y Cajal, Madrid, Spain., Functional Urology Section, Urology Service, University Hospital Puerta del Mar, Cádiz, Spain., Functional and Reconstructive Urology Section, Urology Service, HU la Fe, Valencia, Spain.